ReviewJournal of hematology & oncology2022

BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies.

Aqu Alu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.